Metprofix-25
July 1, 2026
Rosulive-20
July 1, 2026
Metprofix-50 XL
Metoprolol Succinate Er Tablets 50 mg
Metprofix-50 XL Tablet is a once-daily extended-release formulation containing Metoprolol Succinate ER Tablets 50mg, a beta-1 selective adrenergic blocker. This medication is primarily used in the treatment of hypertension (high blood pressure), angina (chest pain), and chronic heart failure, and plays a vital role in post-myocardial infarction care. It effectively helps reduce the risk of future cardiovascular events by controlling heart rate, reducing blood pressure, and improving overall heart function.
As an extended-release formulation, Metprofix-50 XL ensures a steady release of the drug over 24 hours, providing round-the-clock therapeutic coverage. By selectively blocking beta-1 receptors in the heart, it reduces the effects of stress hormones such as adrenaline, helping to slow down the heart rate and lower the workload on the heart. This results in better control of blood pressure and prevention of heart-related complications.
Metprofix-50 XL is commonly prescribed as part of long-term cardiovascular therapy. It not only helps control elevated blood pressure but also supports patients with stable angina by reducing the frequency and severity of chest pain. In patients with chronic heart failure, it improves exercise tolerance and reduces the need for hospitalization. The 50mg strength is often used for moderate hypertension or as a step-up dose in patients who require enhanced beta-blocker support.
This medicine is well-tolerated when taken regularly and under medical supervision. Lifestyle modifications such as salt reduction, weight management, regular exercise, and stress control should be practiced alongside therapy for optimal results.
It is important for patients not to discontinue the medicine abruptly, as sudden withdrawal may lead to chest pain, high blood pressure spikes, or even heart attacks in those with pre-existing cardiac conditions.
Possible side effects include fatigue, dizziness, bradycardia (slow heart rate), hypotension, and cold hands or feet.
Indicated for the management of hypertension, angina, and chronic heart failure.
Do not discontinue the medicine abruptly; consult your doctor before making any changes to dosage or therapy.
Store in a cool, dry place below 30°C. Protect from light and moisture.
Metprofix-50 XL Tablet is a once-daily extended-release formulation containing Metoprolol Succinate ER Tablets 50mg, a beta-1 selective adrenergic blocker. This medication is primarily used in the treatment of hypertension (high blood pressure), angina (chest pain), and chronic heart failure, and plays a vital role in post-myocardial infarction care. It effectively helps reduce the risk of future cardiovascular events by controlling heart rate, reducing blood pressure, and improving overall heart function.
As an extended-release formulation, Metprofix-50 XL ensures a steady release of the drug over 24 hours, providing round-the-clock therapeutic coverage. By selectively blocking beta-1 receptors in the heart, it reduces the effects of stress hormones such as adrenaline, helping to slow down the heart rate and lower the workload on the heart. This results in better control of blood pressure and prevention of heart-related complications.
Metprofix-50 XL is commonly prescribed as part of long-term cardiovascular therapy. It not only helps control elevated blood pressure but also supports patients with stable angina by reducing the frequency and severity of chest pain. In patients with chronic heart failure, it improves exercise tolerance and reduces the need for hospitalization. The 50mg strength is often used for moderate hypertension or as a step-up dose in patients who require enhanced beta-blocker support.
This medicine is well-tolerated when taken regularly and under medical supervision. Lifestyle modifications such as salt reduction, weight management, regular exercise, and stress control should be practiced alongside therapy for optimal results.
It is important for patients not to discontinue the medicine abruptly, as sudden withdrawal may lead to chest pain, high blood pressure spikes, or even heart attacks in those with pre-existing cardiac conditions.
